Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer
Pharmacokinetic and Pharmacodynamic Study of S-1 and Its Effects in Patients With the Digestive Organ Cancer With Reference to Genetic Polymorphism and Activity of CYP2A6 and DPD